Gorilla Technology Chosen to Participate in UK Tech Delegation Visit to Southeast Asia 11-03-2023, 00:23

Carbon Fibre Grand Challenge Launches Phase III 15-03-2023, 23:44

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection 22-10-2024, 19:00